Key Highlights: Implications: Relopduo gives BMS a next‑generation immunotherapy in India’s melanoma market, combining PD‑1 and LAG‑3 blockade to offer materially better pro...
Home / LAG-3 inhibitor
Browsing Tag: LAG-3 inhibitor
Featured Posts
1
Top 10 Indian BioPharma Companies of 2026
July 28, 20262
3
Sun Pharmaceutical Industries
July 27, 2026